Elevation Oncology Inc logo

Elevation Oncology Inc

$ 0.93 -0.0298 (-3.1%) 10:08 PM EST
P/E:
At Loss
P/B:
0.32
Market Cap:
$ 21.67M
Enterprise V:
$ -56.23M
Volume:
20.80K
Avg Vol (2M):
37.84K
Volume:
20.80K
Market Cap $:
21.67M
PE Ratio:
At Loss
Avg Vol (2-Month):
37.84K
Enterprise Value $:
-56.23M
PB Ratio:
0.32

Business Description

Description
Elevation Oncology Inc is an oncology company focused on the development of targeted therapeutics for the treatment of cancer in genomically defined patient populations. Its lead program is focused on neuregulin-1, or NRG1, fusions, which are rare genomic alterations that have the potential to be therapeutically actionable through targeted HER3 inhibition.
Name Current Vs Industry Vs History
Cash-To-Debt 3.69
Equity-to-Asset 0.6
Debt-to-Equity 0.44
Debt-to-EBITDA -0.34
Interest Coverage N/A
N/A
N/A
Piotroski F-Score N/A/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 45.67
9-Day RSI 45.88
14-Day RSI 45.28
6-1 Month Momentum % -54.03
12-1 Month Momentum % -82.33

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 7.29
Quick Ratio 7.29
Cash Ratio 7.14

Dividend & Buy Back

Name Current Vs Industry Vs History
Name Current Vs Industry Vs History
ROE % -73.09
ROA % -63.21
ROIC % -5965.17
ROC (Joel Greenblatt) % -169241.11
ROCE % -69.59